Cardioprotective mechanism of S-nitroso-N-acetylcysteine via S-nitrosated betadrenoceptor-2 in the LDLr-/- mice
dc.contributor.author | Wanschel, Amarylis Claudine Bonito Azeredo | |
dc.contributor.author | Caceres, Viviane de Menezes [UNIFESP] | |
dc.contributor.author | Moretti, Ana Iochabel Soares | |
dc.contributor.author | Bruni-Cardoso, Alexandre | |
dc.contributor.author | Carvalho, Hernandes Faustino de | |
dc.contributor.author | Souza, Heraldo Possolo de | |
dc.contributor.author | Laurindo, Francisco Rafael Martins | |
dc.contributor.author | Spadari, Regina Celia [UNIFESP] | |
dc.contributor.author | Krieger, Marta Helena | |
dc.contributor.institution | NYU | |
dc.contributor.institution | Universidade Estadual de Campinas (UNICAMP) | |
dc.contributor.institution | Universidade Federal de São Paulo (UNIFESP) | |
dc.contributor.institution | Universidade de São Paulo (USP) | |
dc.date.accessioned | 2016-01-24T14:35:10Z | |
dc.date.available | 2016-01-24T14:35:10Z | |
dc.date.issued | 2014-01-30 | |
dc.description.abstract | Previous studies from our group have demonstrated the protective effect of S-nitroso-N-acetylcysteine (SNAC) on the cardiovascular system in dyslipidemic LDLr-/- mice that develop atheroma and left ventricular hypertrophy after 15 days on a high fat diet. We have shown that SNAC treatment attenuates plaque development via the suppression of vascular oxidative stress and protects the heart from structural and functional myocardial alterations, such as heart arrhythmia, by reducing cardiomyocyte sensitivity to catecholamines. Here we investigate the ability of SNAC to modulate oxidative stress and cell survival in cardiomyocytes during remodeling and correlation with beta(2)-AR signaling in mediating this protection. Ventricular superoxide (O-2(-)) and hydrogen peroxide (H2O2) generation was measured by HPLC methods to allow quantification of dihydroethidium (DHE) products. Ventricular histological sections were stained using terminal dUTP nick-end labeling (TUNEL) to identify nuclei with DNA degradation (apoptosis) and this was confirmed by Western blot for cleaved caspase-3 and caspase-7 protein expression. the findings show that O-2(-) and H2O2 production and also cell apoptosis were increased during left ventricular hypertrophy (LVH). SNAC treatment reduced oxidative stress during on cardiac remodeling, measured by decreased H2O2 and O-2(-) production (65% and 52%, respectively), and a decrease in the ratio of p-Ser1177 eNOS/total eNOS. Left ventricle (LV) from SNAC-treated mice revealed a 4-fold increase in beta(2)-AR expression associated with coupling change to Gi; beta(2)-ARs-S-nitrosation (beta(2)-AR-SNO) increased 61%, while apoptosis decreased by 70%. These results suggest that the cardio-protective effect of SNAC treatment is primarily through its anti-oxidant role and is associated with beta(2)-ARs overexpression and beta(2)-AR-SNO via an anti-apoptotic pathway. (C) 2013 Elsevier Inc. All rights reserved. | en |
dc.description.affiliation | NYU, Sch Med, Marc & Ruti Bell Vasc Biol & Dis Program, Leon H Charney Div Cardiol,Dept Med, New York, NY 10016 USA | |
dc.description.affiliation | State Univ Campinas UNICAMP, Inst Biol, Dept Anat Cellular Biol & Physiol, São Paulo, Brazil | |
dc.description.affiliation | Fed Univ São Paulo UNIFESP, Dept Biosci, São Paulo, Brazil | |
dc.description.affiliation | Univ São Paulo, Dept Emergency Med, BR-09500900 São Paulo, Brazil | |
dc.description.affiliation | Univ São Paulo, Sch Med, Heart Inst InCor, BR-09500900 São Paulo, Brazil | |
dc.description.affiliationUnifesp | Fed Univ São Paulo UNIFESP, Dept Biosci, São Paulo, Brazil | |
dc.description.source | Web of Science | |
dc.format.extent | 58-66 | |
dc.identifier | http://dx.doi.org/10.1016/j.niox.2013.12.003 | |
dc.identifier.citation | Nitric Oxide-biology and Chemistry. San Diego: Academic Press Inc Elsevier Science, v. 36, p. 58-66, 2014. | |
dc.identifier.doi | 10.1016/j.niox.2013.12.003 | |
dc.identifier.file | WOS000330605700008.pdf | |
dc.identifier.issn | 1089-8603 | |
dc.identifier.uri | http://repositorio.unifesp.br/handle/11600/37333 | |
dc.identifier.wos | WOS:000330605700008 | |
dc.language.iso | eng | |
dc.publisher | Elsevier B.V. | |
dc.relation.ispartof | Nitric Oxide-biology and Chemistry | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.rights.license | http://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy | |
dc.subject | Hydrogen peroxide | en |
dc.subject | Superoxide | en |
dc.subject | S-nitroso-N-acetylscysteine | en |
dc.subject | Ventricular hypertrophy | en |
dc.subject | Betadrenoceptor-2 | en |
dc.subject | S-nitrosated | en |
dc.title | Cardioprotective mechanism of S-nitroso-N-acetylcysteine via S-nitrosated betadrenoceptor-2 in the LDLr-/- mice | en |
dc.type | info:eu-repo/semantics/article |
Arquivos
Pacote Original
1 - 1 de 1
Carregando...
- Nome:
- WOS000330605700008.pdf
- Tamanho:
- 1.13 MB
- Formato:
- Adobe Portable Document Format
- Descrição: